| Name | Title | Contact Details |
|---|---|---|
Angie Goldsberry |
Vice President, Product Development | Profile |
Melanie Chin |
VP Product Strategy | Profile |
Colin Meyer |
Chief Research and Development Officer | Profile |
Bhaskar Anand |
Chief Accounting Officer (CAO) | Profile |
Steve Harman |
Vice President, Chief Human Resources Officer | Profile |
Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
Directories team of high-level marketing can-do-it-alls seamlessly join your team, dig in and get things done.
Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera`s European operations are conducted from London by its subsidiary, Alimera Sciences Limited.
Founded in 2013, Aphria is integrating their growing expertise with Health Canada`s new Access to Cannabis for Medical Purposes Regulations (ACMPR) for the medicinal marijuana industry. Possessing greenhouse related growing experience in plant and produce related expertise since 1943, Aphria is positioned to be an industry leader in providing patients with the highest quality medical marijuana. Aphria has developed integrated greenhouse growing solutions specifically focused on quality production of cannabis. With the authorization of quantity scale marijuana growing, Aphria greenhouse operations are a natural fit. Aphria is a licensed producer of Medicinal Marijuana under the Health Canada Regulations. Grown in Greenhouses, Aphria offers premium medical grade cannabis. Located in Leamington in Southwestern Ontario, the heart of the greenhouse-producing sector for plant and produce, Aphria is built from a lengthy background of greenhouse growing and business experience.
BeClinic | Best WordPress theme for clinics and medicine